April 16, 2018 / 9:59 AM / 4 days ago

BRIEF-CSPC Pharmaceutical Group Says Cancer Drug Approved By China FDA

April 16 (Reuters) - CSPC Pharmaceutical Group Ltd :

* “VINORELBINE TARTRATE LIPOSOME INJECTION” GRANTED CLINICAL TRIAL APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION OF PRC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below